Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Isamu Saida
Efficacy and Safety of Two pH-dependent-release Mesalamine Doses in Moderately Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Parallel-Group Study
Intestinal Research
Gastroenterology
Related publications
Direct Comparison of Two Different Mesalamine Formulations for the Induction of Remission in Patients With Ulcerative Colitis: A Double-Blind, Randomized Study
Inflammatory Bowel Diseases
Allergy
Immunology
Gastroenterology
Modified-Release Prednisone for Polymyalgia Rheumatica: A Multicentre, Randomised, Active-Controlled, Double-Blind, Parallel-Group Study
RMD Open
Rheumatology
Allergy
Immunology
Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Once Daily Versus Conventional Dosing of pH-dependent Mesalamine Long-Term to Maintain Quiescent Ulcerative Colitis: Preliminary Results From a Randomized Trial
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Protocol of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (NICOFA)
Neurological Research and Practice
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis
Gastroenterology
Hepatology
Gastroenterology
Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Confirmatory Phase 2 Study
Clinical and Experimental Nephrology
Physiology
Nephrology
A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Efficacy, Safety, and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: A Randomized, Double-Blind Phase 3 Study, MEASURE 3
Arthritis Research & Therapy
